Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 471

1.

Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.

Scabini S, Rimini E, Romairone E, Scordamaglia R, Pertile D, Ferrando V.

Minerva Chir. 2009 Jun;64(3):303-6.

PMID:
19536056
2.

Surgical resection of stage IV colorectal cancer and prognosis.

Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K, Ihara A, Nakamura T, Onosato W, Watanabe M.

World J Surg. 2008 Jun;32(6):1130-7. doi: 10.1007/s00268-008-9535-7.

PMID:
18340483
3.

Survival in surgical palliative resection of stage IV colorectal cancer: short term results in a single institution.

Scabini S, Rimini E, Romairone E, Scordamaglia R, Pertile D, Ferrando V.

Minerva Chir. 2010 Feb;65(1):17-20.

PMID:
20212413
4.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
5.

Metastatic potential in T1 and T2 colorectal cancer.

Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1688-91.

PMID:
16334758
6.

Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.

Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ, Lee MJ, Kim WH, Park JG.

J Surg Oncol. 2006 Jan 1;93(1):13-8; discussion 18-9.

PMID:
16353185
7.

Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.

Ann Surg Oncol. 2008 Dec;15(12):3433-9. doi: 10.1245/s10434-008-0168-8. Epub 2008 Oct 10.

PMID:
18846401
8.

Outcome of colorectal carcinoma in patients under 40 years of age.

Lin JT, Wang WS, Yen CC, Liu JH, Yang MH, Chao TC, Chen PM, Chiou TJ.

J Gastroenterol Hepatol. 2005 Jun;20(6):900-5.

PMID:
15946138
9.

Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.

Wang JY, Lu CY, Chu KS, Ma CJ, Wu DC, Tsai HL, Yu FJ, Hsieh JS.

Eur Surg Res. 2007;39(4):245-50. Epub 2007 Apr 23.

PMID:
17457032
10.

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.

Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M.

J Surg Oncol. 2008 Dec 1;98(7):540-4. doi: 10.1002/jso.21154.

PMID:
18937231
11.

Can preoperative and postoperative CEA predict survival after colon cancer resection?

Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM.

Am Surg. 1994 Jul;60(7):528-31; discussion 531-2.

PMID:
8010568
12.

Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

Filiz AI, Sucullu I, Kurt Y, Karakas DO, Gulec B, Akin ML.

Clinics (Sao Paulo). 2009;64(4):287-94.

13.

Predictors of distant metastasis and mortality in patients with stage II colorectal cancer.

Heinzerling JH, Anthony T, Livingston EH, Huerta S.

Am Surg. 2007 Mar;73(3):230-8.

PMID:
17375777
14.

Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.

Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY.

BMC Cancer. 2009 Aug 20;9:288. doi: 10.1186/1471-2407-9-288.

15.

Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.

Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K.

Ann Surg Oncol. 2012 Oct;19(11):3422-31. doi: 10.1245/s10434-012-2384-5. Epub 2012 May 11.

PMID:
22576063
16.

Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.

Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.

Clin Chim Acta. 2007 May 1;380(1-2):208-12. Epub 2007 Feb 27.

PMID:
17368603
17.

Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.

Cianchi F, Messerini L, Comin CE, Boddi V, Perna F, Perigli G, Cortesini C.

Dis Colon Rectum. 2007 Sep;50(9):1332-41.

PMID:
17429709
18.

Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.

El-Awady S, Lithy R, Morshed M, Khafagy W, Abd Monem H, Waleed O, Badr S, Fekry A, El Nakeeb A, Ghazy H, El Yamany M, Metwally T, El-Arman M, Farid M.

Hepatogastroenterology. 2009 Mar-Apr;56(90):361-6.

PMID:
19579599
19.

Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.

Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.

Ann Surg Oncol. 2007 Apr;14(4):1272-84. Epub 2007 Jan 9.

PMID:
17211733
20.

Supplemental Content

Support Center